These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3681094)

  • 21. [Nocturnal paroxysmal hemoglobinuria. Studies on the mechanism of hemolysis].
    KIRCHMAYER S; KOJ A; MOSTOWSKI J; SZCZEPKOWSKI TW
    Pol Arch Med Wewn; 1962; 32():343-52. PubMed ID: 14456255
    [No Abstract]   [Full Text] [Related]  

  • 22. THE ACTION OF TWO SULFHYDRYL COMPOUNDS ON NORMAL HUMAN RED CELLS. RELATIONSHIP TO RED CELLS OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.
    SIRCHIA G; FERRONE S; MERCURIALI F
    Blood; 1965 Apr; 25():502-10. PubMed ID: 14284339
    [No Abstract]   [Full Text] [Related]  

  • 23. Complement-mediated haemolysis and the role of blood transfusion in paroxysmal nocturnal haemoglobinuria.
    Olutogun T; Cutini I; Notaro R; Luzzatto L
    Blood Transfus; 2015 Jul; 13(3):363-9. PubMed ID: 25761313
    [No Abstract]   [Full Text] [Related]  

  • 24. Paroxysmal nocturnal hemoglobinuria. Alternate-complement-pathway-mediated lysis induced by magnesium.
    May JE; Rosse W; Frank MM
    N Engl J Med; 1973 Oct; 289(14):705-9. PubMed ID: 4727529
    [No Abstract]   [Full Text] [Related]  

  • 25. Complement-mediated lysis in different cationic media of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria.
    Pizzimenti MC; Vacs E; Dalmasso AP
    Proc Soc Exp Biol Med; 1974 Jan; 145(1):215-9. PubMed ID: 4812854
    [No Abstract]   [Full Text] [Related]  

  • 26. The in vitro lysis of the red cells of paroxysmal nocturnal haemoglobinuria by the serum of patients with cirrhosis of the liver.
    Sirchia G; Ferrone S; Mercuriali F
    Br J Haematol; 1969 Mar; 16(3):269-75. PubMed ID: 4978548
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.
    Hillmen P; Hall C; Marsh JC; Elebute M; Bombara MP; Petro BE; Cullen MJ; Richards SJ; Rollins SA; Mojcik CF; Rother RP
    N Engl J Med; 2004 Feb; 350(6):552-9. PubMed ID: 14762182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria.
    Holguin MH; Wilcox LA; Bernshaw NJ; Rosse WF; Parker CJ
    J Clin Invest; 1989 Nov; 84(5):1387-94. PubMed ID: 2478585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mechanism of hemolysis in paroxysmal nocturnal hemoglobinuria in the light of personal investigations.
    KIRCHMAYER S
    Acta Med Pol; 1960; 1(3-4)():143-63. PubMed ID: 13756214
    [No Abstract]   [Full Text] [Related]  

  • 30. Erythrocyte vesiculation in paroxysmal nocturnal hemoglobinuria.
    Pan H; Ji Z; Liu E; Zhang Z
    Chin Med Sci J; 1991 Jun; 6(2):84-6. PubMed ID: 1725134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. II. The role of complement components in the increased sensitivity of PNH red cells to immune lysis.
    Rosse WF; Dacie JV
    J Clin Invest; 1966 May; 45(5):749-57. PubMed ID: 4956901
    [No Abstract]   [Full Text] [Related]  

  • 32. Paroxysmal nocturnal hemoglobinuria. I. Clinical features and investigations on the hemolytic tendency.
    PALMER H; VEFLINGSTAD H
    Scand J Clin Lab Invest; 1955; 7(2):115-20. PubMed ID: 13255804
    [No Abstract]   [Full Text] [Related]  

  • 33. Paroxysmal nocturnal hemoglobinuria: the effect of dextran on hemolysis in vitro.
    CROSBY WH; BENJAMIN NR
    Acta Haematol; 1958; 19(4-5):193-8. PubMed ID: 13558967
    [No Abstract]   [Full Text] [Related]  

  • 34. Study of in vitro lysis of paroxysmal nocturnal haemoglobinuria (PNH) and PNH-like red cells.
    Ferrone S; Marubini E; Mercuriali F; Sirchia G
    Br J Haematol; 1972 Jul; 23(1):5-12. PubMed ID: 5045962
    [No Abstract]   [Full Text] [Related]  

  • 35. Paroxysmal nocturnal hemoglobinuria; relationship of in vitro and in vivo hemolysis to clinical severity.
    HINZ CF; HURLEY TH; WEISMAN R
    J Lab Clin Med; 1956 Oct; 48(4):495-510. PubMed ID: 13367588
    [No Abstract]   [Full Text] [Related]  

  • 36. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody.
    Rosse WF; Dacie JV
    J Clin Invest; 1966 May; 45(5):736-48. PubMed ID: 5935361
    [No Abstract]   [Full Text] [Related]  

  • 37. THE INITIATION AND ENHANCEMENT OF HUMAN RED CELL LYSIS BY ACTIVATORS OF THE FIRST COMPONENT OF COMPLEMENT AND BY FIRST COMPONENT ESTERASE; STUDIES USING NORMAL RED CELLS AND RED CELLS FROM PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.
    YACHNIN S; RUTHENBERG JM
    J Clin Invest; 1965 Apr; 44(4):518-34. PubMed ID: 14278168
    [No Abstract]   [Full Text] [Related]  

  • 38. The membrane abnormalities in paroxysmal nocturnal hemoglobinuria (PNH).
    Rosse WF; Adams JP
    Prog Clin Biol Res; 1979; 30():457-61. PubMed ID: 531036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The properdin system and immunity. IV. The hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria.
    HINZ CF; JORDAN WS; PILLEMER L
    J Clin Invest; 1956 May; 35(5):453-7. PubMed ID: 13319478
    [No Abstract]   [Full Text] [Related]  

  • 40. Paroxysmal nocturnal hemoglobinuria: an historical overview.
    Parker CJ
    Hematology Am Soc Hematol Educ Program; 2008; ():93-103. PubMed ID: 19074065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.